Oligometastatic disease in pancreatic ductal adenocarcinoma: A critical appraisal of evidence standards for emerging definitions
Pancreatology · 2026-08 · 26 (5) · 801-802
DOI: 10.1016/j.pan.2026.04.018 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pancreatology, 2026-08. Verfasst von Mauro Iannopollo. Beteiligte Einrichtung: Medical Oncology Unit (SOC), Azienda USL Toscana Centro, Ospedali di Pistoia e Pescia, Pistoia, Italy. Electronic address: mauro.iannopollo@uslcentro…. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Medical Oncology Unit (SOC), Azienda USL Toscana Centro, Ospedali di Pistoia e Pescia, Pistoia, Italy. Electronic address: mauro.iannopollo@uslcentro.toscana.it.
Zitieren
APA
Iannopollo, M. (2026). Oligometastatic disease in pancreatic ductal adenocarcinoma: A critical appraisal of evidence standards for emerging definitions. Pancreatology, 26(5), 801-802. https://doi.org/10.1016/j.pan.2026.04.018
Vancouver
Iannopollo M. Oligometastatic disease in pancreatic ductal adenocarcinoma: A critical appraisal of evidence standards for emerging definitions. Pancreatology. 2026;26(5):801-802. doi:10.1016/j.pan.2026.04.018
BibTeX
@article{Iannopollo2026,
author = {Iannopollo, Mauro},
title = {Oligometastatic disease in pancreatic ductal adenocarcinoma: A critical appraisal of evidence standards for emerging definitions},
journal = {Pancreatology},
year = {2026},
volume = {26},
number = {5},
pages = {801--802},
doi = {10.1016/j.pan.2026.04.018}
}
EUVIMED